Literature DB >> 19842624

Multi-assay-based structure-activity relationship models: improving structure-activity relationship models by incorporating activity information from related targets.

Xia Ning1, Huzefa Rangwala, George Karypis.   

Abstract

Structure-activity relationship (SAR) models are used to inform and to guide the iterative optimization of chemical leads, and they play a fundamental role in modern drug discovery. In this paper, we present a new class of methods for building SAR models, referred to as multi-assay based, that utilize activity information from different targets. These methods first identify a set of targets that are related to the target under consideration, and then they employ various machine learning techniques that utilize activity information from these targets in order to build the desired SAR model. We developed different methods for identifying the set of related targets, which take into account the primary sequence of the targets or the structure of their ligands, and we also developed different machine learning techniques that were derived by using principles of semi-supervised learning, multi-task learning, and classifier ensembles. The comprehensive evaluation of these methods shows that they lead to considerable improvements over the standard SAR models that are based only on the ligands of the target under consideration. On a set of 117 protein targets, obtained from PubChem, these multi-assay-based methods achieve a receiver-operating characteristic score that is, on the average, 7.0 -7.2% higher than that achieved by the standard SAR models. Moreover, on a set of targets belonging to six protein families, the multi-assay-based methods outperform chemogenomics-based approaches by 4.33%.

Mesh:

Year:  2009        PMID: 19842624     DOI: 10.1021/ci900182q

Source DB:  PubMed          Journal:  J Chem Inf Model        ISSN: 1549-9596            Impact factor:   4.956


  8 in total

1.  Multi-task learning for pKa prediction.

Authors:  Grigorios Skolidis; Katja Hansen; Guido Sanguinetti; Matthias Rupp
Journal:  J Comput Aided Mol Des       Date:  2012-06-20       Impact factor: 3.686

2.  QSAR modeling: where have you been? Where are you going to?

Authors:  Artem Cherkasov; Eugene N Muratov; Denis Fourches; Alexandre Varnek; Igor I Baskin; Mark Cronin; John Dearden; Paola Gramatica; Yvonne C Martin; Roberto Todeschini; Viviana Consonni; Victor E Kuz'min; Richard Cramer; Romualdo Benigni; Chihae Yang; James Rathman; Lothar Terfloth; Johann Gasteiger; Ann Richard; Alexander Tropsha
Journal:  J Med Chem       Date:  2014-01-06       Impact factor: 7.446

3.  Multi-task learning with a natural metric for quantitative structure activity relationship learning.

Authors:  Noureddin Sadawi; Ivan Olier; Joaquin Vanschoren; Jan N van Rijn; Jeremy Besnard; Richard Bickerton; Crina Grosan; Larisa Soldatova; Ross D King
Journal:  J Cheminform       Date:  2019-11-12       Impact factor: 5.514

4.  A unified drug-target interaction prediction framework based on knowledge graph and recommendation system.

Authors:  Qing Ye; Chang-Yu Hsieh; Ziyi Yang; Yu Kang; Jiming Chen; Dongsheng Cao; Shibo He; Tingjun Hou
Journal:  Nat Commun       Date:  2021-11-22       Impact factor: 14.919

5.  Improving Compound Activity Classification via Deep Transfer and Representation Learning.

Authors:  Vishal Dey; Raghu Machiraju; Xia Ning
Journal:  ACS Omega       Date:  2022-03-11

6.  Integrated QSAR study for inhibitors of Hedgehog Signal Pathway against multiple cell lines:a collaborative filtering method.

Authors:  Jun Gao; Dongsheng Che; Vincent W Zheng; Ruixin Zhu; Qi Liu
Journal:  BMC Bioinformatics       Date:  2012-07-31       Impact factor: 3.169

7.  Screening of selective histone deacetylase inhibitors by proteochemometric modeling.

Authors:  Dingfeng Wu; Qi Huang; Yida Zhang; Qingchen Zhang; Qi Liu; Jun Gao; Zhiwei Cao; Ruixin Zhu
Journal:  BMC Bioinformatics       Date:  2012-08-22       Impact factor: 3.169

Review 8.  Drug Design for CNS Diseases: Polypharmacological Profiling of Compounds Using Cheminformatic, 3D-QSAR and Virtual Screening Methodologies.

Authors:  Katarina Nikolic; Lazaros Mavridis; Teodora Djikic; Jelica Vucicevic; Danica Agbaba; Kemal Yelekci; John B O Mitchell
Journal:  Front Neurosci       Date:  2016-06-10       Impact factor: 4.677

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.